Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04034992 · ClinicalTrials.gov registry record
A Study on Patients With Chronic Kidney Disease (CKD) to Assess Treatment Experience and Patterns, Effect of the Treatment, Patient Outcomes and Patient Quality of Life
A clinical trial, sponsored by AstraZeneca.
- Completed
- Registry status
- 1,052
- Enrollment target
NCT04034992: Completed study, sponsored by AstraZeneca.
NCT04034992 is a clinical trial that has completed, run by AstraZeneca. The registered enrollment target is 1,052 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04034992 has completed, sponsored by AstraZeneca.
- COMPLETED
- Registry status
- 1,052 participants
- Enrollment target
Study Summary
DISCOVER CKD is an international observational cohort study in patients with CKD, comprising both prospective and retrospective patient cohorts. The study does not attempt to test any specific a priori hypotheses, is largely descriptive, and utilises data collected only under conditions of routine clinical care.
Primary Outcome
Construct a multinational longitudinal cohort of patients with CKD that can be used for primary and secondary analyses
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,052 participants |
| Start Date | 2019-09-11 |
| Est. Completion | 2023-06-30 |
What the finished NCT04034992 record still lists
NCT04034992 is an observational study that tracks outcomes without assigning an intervention. Its 1,052 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT04034992 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04034992 about?
NCT04034992 is a clinical study titled "A Study on Patients With Chronic Kidney Disease (CKD) to Assess Treatment Experience and Patterns, Effect of the Treatment, Patient Outcomes and Patient Quality of Life". DISCOVER CKD is an international observational cohort study in patients with CKD, comprising both prospective and retrospective patient cohorts. The study does not attempt to test any specific a priori hypotheses, is largely descriptive, and utilises data collected only under conditions of routine c...
What is the current status of trial NCT04034992?
This trial is currently completed. The enrollment target is 1,052 participants. The study started on 2019-09-11. Estimated completion is 2023-06-30.
Who is sponsoring clinical trial NCT04034992?
This trial is sponsored by AstraZeneca, which has 1,285 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04505618 · 1,050 participants · NA
Optical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease
- NCT04511806 · 1,050 participants
Childhood Cancer Predisposition Study (CCPS)
- NCT05028972 · 1,050 participants · NA
Hearing Impairment, Strategies and Outcomes in VA Emergency Departments
- NCT05915377 · 1,050 participants · NA
Researching Efficient Approaches to Delirium Identification-Sustaining Effective Translation
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI